A
Nexgenix Pharmaceuticals 955 Lexington Avenue Category: Biotechnical Research, Commercial |
Company representatives
Dr Allan Rubenstein, Chief Executive Officer
Location Type
Single Location
Revenue
$1,500,000 - $1,750,000
Employees
5 to 9
Years In Business
20
State of incorporation
New York
SIC code
801101 (Physicians & Surgeons)
NAICS code
621111 (Offices of Physicians Except Mental Health)
Rating
Browse U.S. states for Biotechnical Research, Commercial
